Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Gina, Muthoni Ouattara"'
Autor:
Brima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, Mohammed Abdelrahim Saeed, Eltahir Awad Gasim Khalil, Anas Elbashir Ahmed, Mujahid Ahmed Ali, Ali Noureldin, Gina Muthoni Ouattara, Godfrey M Nyakaya, Samuel Teshome, Truphosa Omollo, Michael Ochieng, Thaddaeus Egondi, Mildred Mmbone, Wan-Yu Chu, Thomas P C Dorlo, Eduard E Zijlstra, Monique Wasunna, Jorge Alvar, Fabiana Alves
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 17, Iss 11, p e0011780 (2023)
BackgroundTreatment for post-kala-azar dermal leishmaniasis (PKDL) in Sudan is currently recommended only for patients with persistent or severe disease, mainly because of the limitations of current therapies, namely toxicity and long hospitalization
Externí odkaz:
https://doaj.org/article/8e80fbd2c0f14737b661e76f2ce1ecf5
Autor:
Ahmed M, Musa, Jane, Mbui, Rezika, Mohammed, Joseph, Olobo, Koert, Ritmeijer, Gabriel, Alcoba, Gina, Muthoni Ouattara, Thaddaeus, Egondi, Prossy, Nakanwagi, Truphosa, Omollo, Monique, Wasunna, Luka, Verrest, Thomas P C, Dorlo, Brima, Musa Younis, Ali, Nour, Elmukashfi, Taha Ahmed Elmukashfi, Ahmed, Ismail Omer Haroun, Eltahir A G, Khalil, Simon, Njenga, Helina, Fikre, Tigist, Mekonnen, Dagnew, Mersha, Kasaye, Sisay, Patrick, Sagaki, Jorge, Alvar, Alexandra, Solomos, Fabiana, Alves
Publikováno v:
Clinical Infectious Diseases. 76:e1177-e1185
Background This study aimed to determine whether paromomycin plus miltefosine (PM/MF) is noninferior to sodium stibogluconate plus paromomycin (SSG/PM) for treatment of primary visceral leishmaniasis in eastern Africa. Methods An open-label, phase 3,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfe571622e1e72782a5232658c426563
https://doi.org/10.1093/cid/ciac643
https://doi.org/10.1093/cid/ciac643
Autor:
Graeme Bilbe, Séverine Blesson, Gina Muthoni Ouattara, Byron Arana, Joelle Rode, Vishal Goyal, Susan Wells, Alexandra Solomos, Nathalie Strub-Wourgaft, Eduard E. Zijlstra, Séverine Monnerat, Fabiana Alves, Bernard Pécoul, Monique Wasunna, Suman Rijal, Jorge Alvar, Charles E. Mowbray
Publikováno v:
Clinical Microbiology Reviews. 31
SUMMARY Research in visceral leishmaniasis in the last decade has been focused on how better to use the existing medicines as monotherapy or in combination. Systematic research by geographical regions has shown that a universal treatment is far from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a9259a569cf8854c1efa1ee3aa70840
https://doi.org/10.1128/cmr.00048-18
https://doi.org/10.1128/cmr.00048-18